Pathology News
February 2, 2022 -- Artemis DNA’s two facilities, in Irvine, California and Houston, Texas, are now both CLIA and CAP accredited. Artemis DNA, Inc. (“Artemis DNA” or the “company”), a full-service, accredited, high...
Vabysmo (faricimab-svoa) targets and inhibits two disease pathways that drive wet age-related macular degeneration (AMD) and diabetic macular edema (DME). Vabysmo is the only injectable eye medicine approved simultaneously in the US for wet...
05/26/2021 - A Novel Technology for Cooperative Analysis of Big Data. Communities benefit from sharing knowledge and experience among their members. Following a similar principle - called “swarm learning” - an international research team...
Mountain View, California, January 31, 2022 ─ Crosscope Inc, a Silicon Valley-based leader of AI-enabled Digital Pathology Software, and BALCO Medical Centre, flagship unit of Vedanta Medical Research Foundation (VMRF), are joining hands for...
Artificial intelligence: A promising frontier in bladder cancer diagnosis and outcome prediction Abstract Bladder cancer (BCa) is the most common malignancy of the urinary tract and the most expensive malignancy to treat over the...
January 27, 2022 – The CONDOR consortium, led by Pr. Antoine Italiano of the Bergonié Institute (Bordeaux, France) is one of the 17 national awardees in the fifth call for projects in Hospital-University Research in Health (RHU5),...
